| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 2574-2578, Copyright © 1993 by Endocrine Society
ARTICLES |
N Muramami, J Fukata, T Tsukada, H Kobayashi, O Ebisui, H Segawa, S Muro, H Imura and K Nakao
Department of Medicine, Kyoto University Faculty of Medicine, Japan.
Whereas the stimulatory effect of interleukin-6 (IL-6) on the hypothalamic-pituitary-adrenal (HPA) axis is well established, its mode of action in this axis has yet to be fully elucidated. To further study the role of IL-6 in the HPA axis, we compared the expression of IL-6 messenger RNA (mRNA) in the rat hypothalamus, pituitary, and adrenal gland with that in the spleen after ip or intracerebroventricular (icv) administration of bacterial lipopolysaccharide (LPS). After either ip or icv administration, LPS induced the expression of IL-6 mRNA, which consists of 1.2 kilobases (kb) and 2.4 kb subclasses, in all these tissues of the HPA axis as well as in the spleen. Although we used 100 times less amount of LPS for the icv administration than that used for ip LPS, plasma ACTH levels in both the conditions rapidly reached comparable levels. This icv dose induced IL-6 mRNA expression in the hypothalamus faster than ip dose but also stimulated IL-6 mRNA expression in the hypothalamus, pituitary, and adrenal gland more effectively and smoothly than the ip LPS dose did. Northern blot analysis revealed that in the hypothalamus, pituitary, and adrenals, the predominant subclass of IL-6 mRNA was not 1.2 kb but 2.4 kb. In contrast, this subclass was the minor component in the spleen induced under the same circumstances. These findings indicate that IL-6- synthesizing cells in the HPA axis differ in character from those in the spleen, and that LPS applied in vivo may modulate IL-6 expression in these cells directly and/or indirectly through secondarily activated functions in the neuronal or endocrine systems.
This article has been cited by other articles:
![]() |
E. Yang, P.T. Foteinou, K.R. King, M.L. Yarmush, and I.P. Androulakis A novel non-overlapping bi-clustering algorithm for network generation using living cell array data Bioinformatics, September 1, 2007; 23(17): 2306 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Smith, N. W. Wilson, A. Louw, and K. H. Myburgh Illuminating the interrelated immune and endocrine adaptations after multiple exposures to short immobilization stress by in vivo blocking of IL-6 Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1439 - R1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tierney, R. Patel, C. A. S. Stead, L. Leng, R. Bucala, and J. C. Buckingham Macrophage Migration Inhibitory Factor Is Released from Pituitary Folliculo-Stellate-Like Cells by Endotoxin and Dexamethasone and Attenuates the Steroid-Induced Inhibition of Interleukin 6 Release Endocrinology, January 1, 2005; 146(1): 35 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kondo and A. Togari In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E661 - E667. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lohrer, J. Gloddek, A. C. Nagashima, Z. Korali, U. Hopfner, M. P. Pereda, E. Arzt, G. K. Stalla, and U. Renner Lipopolysaccharide Directly Stimulates the Intrapituitary Interleukin-6 Production by Folliculostellate Cells via Specific Receptors and the p38{{alpha}} Mitogen-Activated Protein Kinase/Nuclear Factor-{{kappa}}B Pathway Endocrinology, December 1, 2000; 141(12): 4457 - 4465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. P. Lenczowski, R.-M. Bluthe, J. Roth, G. S. Rees, D. A. Rushforth, A.-M. van Dam, F. J. H. Tilders, R. Dantzer, N. J. Rothwell, and G. N. Luheshi Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R652 - R658. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Telleria, J. Ou, N. Sugino, S. Ferguson, and G. Gibori The Expression of Interleukin-6 in the Pregnant Rat Corpus Luteum and Its Regulation by Progesterone and Glucocorticoid Endocrinology, August 1, 1998; 139(8): 3597 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Auernhammer, V. Chesnokova, and S. Melmed Leukemia Inhibitory Factor Modulates Interleukin-1{beta}-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis Endocrinology, May 1, 1998; 139(5): 2201 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text] |
||||
![]() |
A. V. Turnbull and C. L. Rivier Intracerebroventricular Passive Immunization. I. The Effect of Intracerebroventricular Administration of an Antiserum to Tumor Necrosis Factor-{alpha} on the Plasma Adrenocorticotropin Response to Lipopolysaccharide in Rats Endocrinology, January 1, 1998; 139(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Raber, R. D. O'Shea, F. E. Bloom, and I. L. Campbell Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice J. Neurosci., December 15, 1997; 17(24): 9473 - 9480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. De Simoni, L. Terreni, R. Chiesa, F. Mangiarotti, and G. L. Forloni Interferon-{gamma} Potentiates Interleukin (IL)-6 and Tumor Necrosis Factor-{alpha} But Not IL-1{beta} Induced by Endotoxin in the Brain Endocrinology, December 1, 1997; 138(12): 5220 - 5226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Turnbull, F. J. Pitossi, J.-J. Lebrun, S. Lee, J. C. Meltzer, D. M. Nance, A. del Rey, H. O. Besedovsky, and C. Rivier Inhibition of Tumor Necrosis Factor-alpha Action within the CNS Markedly Reduces the Plasma Adrenocorticotropin Response to Peripheral Local Inflammation in Rats J. Neurosci., May 1, 1997; 17(9): 3262 - 3273. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text] |
||||
![]() |
J.-M. Aubry, A. V. Turnbull, G. Pozzoli, C. Rivier, and W. Vale Endotoxin Decreases Corticotropin-Releasing Factor Receptor 1 Messenger Ribonucleic Acid Levels in the Rat Pituitary Endocrinology, April 1, 1997; 138(4): 1621 - 1626. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |